These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19506150)

  • 1. "Staging the aging" when considering androgen deprivation therapy for older men with prostate cancer.
    Dale W
    J Clin Oncol; 2009 Jul; 27(21):3420-2. PubMed ID: 19506150
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
    Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
    Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing hot flashes in men being treated for prostate cancer.
    Baum NH; Torti DC
    Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic effects of testosterone deprivation.
    Sprenkle PC; Fisch H
    Curr Opin Urol; 2007 Nov; 17(6):424-30. PubMed ID: 17921778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
    Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot flashes in prostate cancer: state of the science.
    Engstrom CA
    Am J Mens Health; 2008 Jun; 2(2):122-32. PubMed ID: 19477776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage D1 prostate cancer--delayed androgen deprivation.
    Richie JP
    Urology; 1997 Dec; 50(6):838-9. PubMed ID: 9426710
    [No Abstract]   [Full Text] [Related]  

  • 8. Androgen deprivation therapy for prostate cancer.
    Bahnson R
    J Urol; 2007 Oct; 178(4 Pt 1):1148. PubMed ID: 17698142
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing complications of androgen deprivation therapy for prostate cancer.
    Holzbeierlein JM
    Urol Clin North Am; 2006 May; 33(2):181-90, vi. PubMed ID: 16631456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hot flushes for men treated with androgen deprivation therapy for prostate cancer: a survey of UK practice.
    Kinnaird W; Mehta A; Guo C; Payne H; Jenkins V; Catt S
    Acupunct Med; 2021 Aug; 39(4):394-395. PubMed ID: 33023298
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring hot flashes in men treated with hormone ablation therapy: an unmet need.
    Kattan MW
    Urol Nurs; 2006 Feb; 26(1):13-8. PubMed ID: 16562382
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular risk during androgen deprivation therapy for prostate cancer.
    Jones TH
    BMJ; 2011 May; 342():d3105. PubMed ID: 21610041
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
    Palma D; Pickles T
    Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications of androgen deprivation therapy in prostate cancer.
    Schwandt A; Garcia JA
    Curr Opin Urol; 2009 May; 19(3):322-6. PubMed ID: 19318949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate for the treatment of hot flashes in men undergoing hormone ablation therapy or orchiectomy.
    Lajiness MJ
    Urol Nurs; 2007 Dec; 27(6):556-7. PubMed ID: 18217540
    [No Abstract]   [Full Text] [Related]  

  • 16. Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy. Commentary.
    Koupparis A
    BJU Int; 2009 Jul; 104(1):124; author reply 124-5. PubMed ID: 19646128
    [No Abstract]   [Full Text] [Related]  

  • 17. Physiology and endocrinology of hot flashes in prostate cancer.
    Engstrom CA; Kasper CE
    Am J Mens Health; 2007 Mar; 1(1):8-17. PubMed ID: 19482779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy.
    Ashamalla H; Jiang ML; Guirguis A; Peluso F; Ashamalla M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1358-63. PubMed ID: 20605360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the side effects of androgen deprivation therapy.
    J Support Oncol; 2006 Feb; 4(2):97-8. PubMed ID: 16499136
    [No Abstract]   [Full Text] [Related]  

  • 20. Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.
    Gonzalez BD; Jim HS; Donovan KA; Small BJ; Sutton SK; Park J; Lin HY; Spiess PE; Fishman MN; Jacobsen PB
    J Urol; 2015 Sep; 194(3):690-5. PubMed ID: 25791402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.